nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—Thalidomide—leprosy	0.148	0.154	CbGbCtD
Methazolamide—CYP2E1—Rifampicin—leprosy	0.143	0.149	CbGbCtD
Methazolamide—CYP2E1—Dapsone—leprosy	0.118	0.123	CbGbCtD
Methazolamide—CYP2C19—Thalidomide—leprosy	0.0929	0.0967	CbGbCtD
Methazolamide—CYP2C19—Rifampicin—leprosy	0.0899	0.0937	CbGbCtD
Methazolamide—CYP2C9—Thalidomide—leprosy	0.0772	0.0804	CbGbCtD
Methazolamide—CYP2C9—Rifampicin—leprosy	0.0748	0.0779	CbGbCtD
Methazolamide—CYP2C19—Dapsone—leprosy	0.0742	0.0773	CbGbCtD
Methazolamide—CYP2C9—Dapsone—leprosy	0.0617	0.0643	CbGbCtD
Methazolamide—CYP3A4—Rifampicin—leprosy	0.0435	0.0453	CbGbCtD
Methazolamide—CYP3A4—Dapsone—leprosy	0.0359	0.0374	CbGbCtD
Methazolamide—CA6—ear—leprosy	0.00576	0.283	CbGeAlD
Methazolamide—Electrolyte imbalance—Thalidomide—leprosy	0.00193	0.0998	CcSEcCtD
Methazolamide—CA1—nerve—leprosy	0.00192	0.0945	CbGeAlD
Methazolamide—CA4—nerve—leprosy	0.0015	0.0739	CbGeAlD
Methazolamide—CA12—eye—leprosy	0.00102	0.0499	CbGeAlD
Methazolamide—Tingling sensation—Thalidomide—leprosy	0.001	0.0519	CcSEcCtD
Methazolamide—Blood disorder—Thalidomide—leprosy	0.000965	0.0499	CcSEcCtD
Methazolamide—CA9—tendon—leprosy	0.000909	0.0446	CbGeAlD
Methazolamide—Photosensitivity reaction—Dapsone—leprosy	0.000902	0.0466	CcSEcCtD
Methazolamide—CA14—tendon—leprosy	0.000862	0.0423	CbGeAlD
Methazolamide—CA1—eye—leprosy	0.000804	0.0395	CbGeAlD
Methazolamide—Aplastic anaemia—Thalidomide—leprosy	0.000757	0.0391	CcSEcCtD
Methazolamide—CA9—testis—leprosy	0.000753	0.037	CbGeAlD
Methazolamide—Tinnitus—Dapsone—leprosy	0.000737	0.0381	CcSEcCtD
Methazolamide—Photosensitivity—Thalidomide—leprosy	0.000666	0.0345	CcSEcCtD
Methazolamide—Vertigo—Dapsone—leprosy	0.000618	0.032	CcSEcCtD
Methazolamide—CA5B—tendon—leprosy	0.000603	0.0296	CbGeAlD
Methazolamide—CA12—nervous system—leprosy	0.000546	0.0268	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000527	0.0273	CcSEcCtD
Methazolamide—CA2—eye—leprosy	0.000521	0.0256	CbGeAlD
Methazolamide—CA5B—testis—leprosy	0.000499	0.0245	CbGeAlD
Methazolamide—CA5B—nervous system—leprosy	0.00049	0.0241	CbGeAlD
Methazolamide—Pancytopenia—Thalidomide—leprosy	0.00048	0.0248	CcSEcCtD
Methazolamide—Photosensitivity reaction—Thalidomide—leprosy	0.000462	0.0239	CcSEcCtD
Methazolamide—CA2—skin of body—leprosy	0.000454	0.0223	CbGeAlD
Methazolamide—Drowsiness—Thalidomide—leprosy	0.000451	0.0233	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000447	0.0231	CcSEcCtD
Methazolamide—Body temperature increased—Dapsone—leprosy	0.000444	0.023	CcSEcCtD
Methazolamide—CA1—nervous system—leprosy	0.000433	0.0213	CbGeAlD
Methazolamide—Haematuria—Thalidomide—leprosy	0.00043	0.0222	CcSEcCtD
Methazolamide—Agranulocytosis—Thalidomide—leprosy	0.000421	0.0218	CcSEcCtD
Methazolamide—CA4—tendon—leprosy	0.000416	0.0204	CbGeAlD
Methazolamide—Erythema multiforme—Thalidomide—leprosy	0.000383	0.0198	CcSEcCtD
Methazolamide—Tinnitus—Thalidomide—leprosy	0.000377	0.0195	CcSEcCtD
Methazolamide—Vomiting—Dapsone—leprosy	0.000357	0.0185	CcSEcCtD
Methazolamide—Headache—Dapsone—leprosy	0.000352	0.0182	CcSEcCtD
Methazolamide—CA2—tendon—leprosy	0.000345	0.017	CbGeAlD
Methazolamide—Dysgeusia—Thalidomide—leprosy	0.000345	0.0178	CcSEcCtD
Methazolamide—CA4—testis—leprosy	0.000345	0.0169	CbGeAlD
Methazolamide—CA4—nervous system—leprosy	0.000338	0.0166	CbGeAlD
Methazolamide—Nausea—Dapsone—leprosy	0.000334	0.0173	CcSEcCtD
Methazolamide—Ill-defined disorder—Thalidomide—leprosy	0.000327	0.0169	CcSEcCtD
Methazolamide—Malaise—Thalidomide—leprosy	0.000318	0.0164	CcSEcCtD
Methazolamide—Vertigo—Thalidomide—leprosy	0.000317	0.0164	CcSEcCtD
Methazolamide—Leukopenia—Thalidomide—leprosy	0.000315	0.0163	CcSEcCtD
Methazolamide—Convulsion—Thalidomide—leprosy	0.000305	0.0158	CcSEcCtD
Methazolamide—Discomfort—Thalidomide—leprosy	0.000296	0.0153	CcSEcCtD
Methazolamide—Confusional state—Thalidomide—leprosy	0.00029	0.015	CcSEcCtD
Methazolamide—CA2—testis—leprosy	0.000286	0.014	CbGeAlD
Methazolamide—CA2—nervous system—leprosy	0.000281	0.0138	CbGeAlD
Methazolamide—CYP2E1—tendon—leprosy	0.000277	0.0136	CbGeAlD
Methazolamide—Anorexia—Thalidomide—leprosy	0.000274	0.0142	CcSEcCtD
Methazolamide—Paraesthesia—Thalidomide—leprosy	0.000258	0.0134	CcSEcCtD
Methazolamide—Somnolence—Thalidomide—leprosy	0.000256	0.0132	CcSEcCtD
Methazolamide—Dyspepsia—Thalidomide—leprosy	0.000253	0.0131	CcSEcCtD
Methazolamide—Decreased appetite—Thalidomide—leprosy	0.00025	0.0129	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Thalidomide—leprosy	0.000248	0.0128	CcSEcCtD
Methazolamide—Fatigue—Thalidomide—leprosy	0.000248	0.0128	CcSEcCtD
Methazolamide—Feeling abnormal—Thalidomide—leprosy	0.000237	0.0123	CcSEcCtD
Methazolamide—CYP2E1—testis—leprosy	0.000229	0.0113	CbGeAlD
Methazolamide—Urticaria—Thalidomide—leprosy	0.000228	0.0118	CcSEcCtD
Methazolamide—Body temperature increased—Thalidomide—leprosy	0.000227	0.0118	CcSEcCtD
Methazolamide—CYP2E1—nervous system—leprosy	0.000225	0.011	CbGeAlD
Methazolamide—Asthenia—Thalidomide—leprosy	0.000206	0.0107	CcSEcCtD
Methazolamide—Diarrhoea—Thalidomide—leprosy	0.000197	0.0102	CcSEcCtD
Methazolamide—Vomiting—Thalidomide—leprosy	0.000183	0.00946	CcSEcCtD
Methazolamide—CYP2D6—testis—leprosy	0.000181	0.00891	CbGeAlD
Methazolamide—Rash—Thalidomide—leprosy	0.000181	0.00938	CcSEcCtD
Methazolamide—Dermatitis—Thalidomide—leprosy	0.000181	0.00937	CcSEcCtD
Methazolamide—CYP3A4—nervous system—leprosy	0.000181	0.00889	CbGeAlD
Methazolamide—Headache—Thalidomide—leprosy	0.00018	0.00932	CcSEcCtD
Methazolamide—CYP2D6—nervous system—leprosy	0.000178	0.00875	CbGeAlD
Methazolamide—Nausea—Thalidomide—leprosy	0.000171	0.00883	CcSEcCtD
